SB 574 Oklahoma Senate · 2025 Regular Session

Attorney General; broadening approved purposes for opioid grant awards; authorizing certain use of funds by the Attorney General. Effective date.

SB 574 expands the Attorney General's authority to use opioid settlement funds by broadening the approved purposes for grant awards. It directly affects the Attorney General's office, allowing them to allocate funds for additional community programs addressing the opioid crisis beyond previous restrictions. Key provisions authorize the Attorney General to use these funds for initiatives like treatment access, harm reduction, and prevention efforts, as specified in the bill text. The bill was passed by the legislature after a veto override (72-10) and is now effective. This change modifies how state opioid settlement money can be spent to support local communities.
Bill status vetoed 4 of 5 stages cleared
Introduction
Feb 2025
Committee Review
May 2025
Senate Passage
Mar 2025
House Passage
May 2025
Vetoed
May 2025
Introduced Feb 3, 2025 Vetoed May 29, 2025
Maddy AI version diff · 4 comparisons

What changed between versions

Floor (House) Floor (Senate) · 8 edits
MODERATE
The bill was amended to transition from the House version to the Senate floor version, incorporating committee amendments that clarify definitions and expand the scope of approved opioid abatement purposes. The changes add new categories for funding and services, including support for pregnant women with opioid use disorder, prevention of overprescribing, and reimbursement for law enforcement costs related to the opioid epidemic. These amendments broaden the program's applicability to better address the multifaceted opioid crisis through expanded service definitions and settlement fund usage.
Scope change
The bill's scope was expanded to include additional approved purposes such as supporting pregnant or parenting women with opioid use disorder, preventing overprescribing, reimbursing law enforcement costs, and supporting youth education about opioid dangers. The definition of 'Opioid funds' was also modified to clarify what settlement amounts are included.
DEFINITION

Added new definitions for 'Board', 'Eligible participant', 'Nonapproved purpose', 'Opioid funds', and 'Opioid grant awards' to clarify program administration and funding sources.

Modified the 'Opioid funds' definition to clarify that it includes all monetary amounts from opioid litigation settlements but excludes other funds received under the Purdue Settlement Agreement.

SCOPE

Added new approved purposes including support for pregnant or parenting women with opioid use disorder and their families, and support for parents and caregivers of babies with neonatal abstinence syndrome.

Added provisions to prevent overprescribing and ensure appropriate prescribing and dispensing of opioids.

Added reimbursement for attorney fees and expenses directly related to opioid litigation incurred through legal services agreements entered before May 21, 2020.

Added support for youth education regarding the dangers of opioid use, abuse, and addiction.

FISCAL

Added reimbursement for law enforcement and emergency responder expenditures related to the opioid epidemic, including emergency response costs and training.

TECHNICAL

Changed document header from 'HOUSE OF REPRESENTATIVES' to 'SENATE FLOOR VERSION' with updated date and formatting adjustments.

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
33
Key actions
9
Committee
8
Amendments
1
May 29, 2025
Introduced
Filed with Secretary of State
upper
May 29, 2025
Vetoed
Veto overridden: Ayes: 72 Nays: 10
lower
May 29, 2025
Vetoed
Veto override message received
lower
May 29, 2025
Vetoed
Veto overridden: Ayes: 33 Nays: 14
upper
May 13, 2025
Vetoed
Vetoed 05/13/2025
upper
May 6, 2025
Committee
Referred for enrollment
upper
May 6, 2025
Lower · Passed
Third Reading, Measure passed: Ayes: 66 Nays: 17
lower
Apr 16, 2025
Lower · Passed
CR; Do Pass Health and Human Services Oversight Committee
lower
Apr 9, 2025
Lower · Passed
Policy recommendation to the Health and Human Services Oversight committee; Do Pass Alcohol, Tobacco and Controlled Substances
lower
Apr 1, 2025
Committee
Referred to Alcohol, Tobacco and Controlled Substances
lower
Mar 25, 2025
Introduced
First Reading
lower
Mar 25, 2025
Upper · Passed
Engrossed to House
upper
Mar 24, 2025
Committee
Referred for engrossment
upper
Mar 24, 2025
Upper · Passed
Measure passed: Ayes: 39 Nays: 7
upper
Mar 24, 2025
Introduced
General Order, Amended
upper
Feb 26, 2025
Upper · Passed
Reported Do Pass as amended Appropriations committee; CR filed
upper
Feb 19, 2025
Committee
Referred to Appropriations
upper
Feb 19, 2025
Upper · Passed
Reported Do Pass as amended Judiciary committee; CR filed
upper
Feb 3, 2025
Introduced
First Reading
upper
2 primary · 0 co-sponsors

Sponsors